A visual guide to vaccines for the routine vaccination programme
Updated 30 August 2024
Infanrix hexa or Vaxelis
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Infanrix hexa (GSK) or Vaxelis (Sanofi Pasteur) Hexavalent vaccine DTaP/IPV/Hib/HepB | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | 8, 12 and 16 weeks |
Rotarix
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Rotarix (GSK) Rotavirus (oral) | Rotavirus gastroenteritis | 8 weeks and 12 weeks |
Bexsero
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Bexsero (GSK) MenB | Meningococcal group B | 8 weeks, 16 weeks and one year |
Prevenar 13
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Prevenar 13 (Pfizer) PCV | Pneumococcal (13 serotypes) | 12 weeks and one year |
Menitorix
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Menitorix (GSK) Hib/MenC | Haemophilus influenzae type b (Hib) and meningococcal group C | One year |
MMRvaxPro or Priorix
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
MMRvaxPro (MSD) or Priorix (GSK) MMR | Measles, mumps and rubella | One year and 3 years, 4 months |
Boostrix-IPV
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Boostrix-IPV (GSK) dTaP/IPV | Diphtheria, tetanus, pertussis and polio | 3 years, 4 months |
Gardasil 9
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Gardasil 9 (MSD) HPV | Cancers and genital warts caused by specific human papillomavirus (HPV) types | Boys and girls aged 12 to 13 years (school Year 8) |
Revaxis
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Revaxis (Sanofi Pasteur) Td/IPV | Tetanus, diphtheria and polio | 14 years (school Year 9) |
MenQuadfi
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
MenQuadfi (Sanofi) MenACWY | Meningococcal groups A, C, W and Y | 14 years (school Year 9) |
ADACEL
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
ADACEL (Sanofi) Tdap | Tetanus, diphtheria and pertussis (whooping cough) | Pregnant women from 16 weeks gestation |
Abrysvo
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Abrysvo (Pfizer) RSV | Respiratory Syncytial Virus | Pregnant women from 28 weeks gestation 75 years (1) |
Pneumovax 23
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Pneumovax 23 (MSD) PPV | Pneumococcal (23 serotypes) | 65 years (and certain at-risk groups) (2) |
Shingrix
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Shingrix (GSK) Shingles | Shingles | Eligible groups (3): 50+ years if severely immunocompromised 70+ years if Zostavax is not available |
Zostavax
Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
---|---|---|
Zostavax (MSD) Shingles | Shingles | 70+ years (immunocompetent)(3) |
Full schedule
Read full details of the routine immunisation schedule.
References
1. RSV vaccination programme
2. The Green Book: Pneumococcal chapter 25
3. Shingles guidance and vaccination programme